IWC
ENTA icon

Integrated Wealth Concepts’s Enanta Pharmaceuticals ENTA Stock Holding History

Integrated Wealth Concepts’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.32K Buy
+159
New +$2.14K ﹤0.01% 5308

Other funds holding ENTA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Integrated Wealth Concepts's ENTA Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Enanta Pharmaceuticals (ENTA) in Q2 2026: 159 shares worth $2.32K. The stake represents ﹤0.01% of the portfolio and ranks #5308 among its holdings.

122 funds tracked by Wall St. Rank hold ENTA as of Q2 2026.

  • Integrated Wealth Concepts held 159 shares of Enanta Pharmaceuticals worth $2.32K as of Q2 2026.
  • Enanta Pharmaceuticals was a new Integrated Wealth Concepts position in Q2 2026.
  • Enanta Pharmaceuticals made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #5308 holding.
  • 122 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.